drugset / Trial / NCT00471848
Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia
Phase 2
Completed
35 enrolled
European Society for Blood and Marrow Transplantation
Genzyme, a Sanofi Company · collab
NaSingle-groupOpen-labelTreatment
Summary
To assess the tolerability and effectiveness of rabbit antithymocyte globulin (ATG, Thymoglobuline) with ciclosporin in the first line treatment of patients with acquired severe aplastic anaemia, and patients with non-severe aplastic anaemia and who are transfusion dependent.
Timeline
- Start
- 2008-08
- Primary completion
- 2011-10
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thymoglobulin | Protein / enzyme biologic | 1.5 unknown | — |